YGYiming Gao

Yiming Gao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yiming Gao has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Innovative Learning Tools in Breast Imaging

    by Benjamin Vega, Yiming Gao

    Radiology and breast imaging curricula have relied almost entirely on passive learning tools such as lectures, books, journal articles, and videos for more than two decades. Despite their wide availability, trainee engagement with these tools to accumulate and synthesize the vast amount of information required to succeed in radiology remains challenging. Knowledge gaps exist among trainees because of natural differences in learning styles, study habits, and case exposure at the reading station. Further, current pressures in academic radiology limit the availability of workstation teaching, which is the most effective teaching and learning strategy in the field. Leading educators aim to bridge these gaps both by leveraging artificial intelligence (AI) large language models (LLM) to develop precision learning curricula personalized to the trainee and by creating gamified learning tools to boost the engagement of trainees. Gamification can also be used to simulate learning experiences for trainees. These tools show promise based on user feedback, both by educators and learners. Further, the synergy of AI and gamification strategies may help address knowledge gaps precisely and efficiently. We explore some of these emerging tools, their application, potential benefits, and limitations within radiology with a focus on breast imaging training.

  • Bridging the Physician Knowledge Gap in Transgender and Gender-Diverse Breast Imaging Care

    by Evelyn F Carroll, Yiming Gao

    Transgender and gender-diverse (TGD) individuals face unique challenges in accessing affirming, evidence-based breast imaging care because of longstanding disparities in provider education, institutional practices, and imaging guidelines. Gender-affirming hormone therapy and gender-affirming surgeries, such as chest masculinization or breast augmentation, impact breast tissue composition and cancer risk, necessitating individualized imaging approaches. Through multiple clinical vignettes, this article illustrates potential pitfalls and key considerations in breast imaging for TGD patients, including appropriate imaging recommendations, inclusive system-level changes, and navigating patient encounters. Education of breast imaging radiologists, technologists, and front-desk staff is critical to bridge the known knowledge gap and improve outcomes for this patient population. By adopting inclusive, culturally competent, and trauma-informed practices, breast imaging professionals can help reduce disparities and improve the experience and health outcomes of TGD patients.


  • Breast Imaging Essentials

    by Yiming Gao, Samantha L. Heller

  • Update on Lobular Neoplasia

    by Samantha L. Heller, Yiming Gao

    Lobular neoplasia (LN) is a histopathologic entity that encompasses both lobular carcinoma in situ (LCIS) and atypical lobular hyperplasia (ALH). Management of LN is known to be variable and institutionally dependent. The variability in approach after a diagnosis of LN at percutaneous breast biopsy derives in part from heterogeneity in the literature, resulting in a range of reported upgrade rates to malignancy after initial identification at percutaneous biopsy, and also from historical shifts in understanding of the natural history of LN. It has become increasingly recognized that not all LN is the same and that distinct variants of LN such as pleomorphic LCIS and florid LCIS have distinct natural histories and distinct likelihoods of upgrade to malignancy. In addition, it is also increasingly understood that appropriate management of LN relies on scrupulous radiologic-pathologic correlation. This review details the imaging features and histopathologic nature of ALH, classic-type LCIS, and the LCIS variants; addresses changes in the historical understanding of this entity contributing to confusion regarding its management; and discusses the importance of performing radiologic-pathologic correlation after percutaneous biopsy to help guide appropriate management steps when LN is encountered. In addition to the short-term implications of an LN diagnosis in terms of upgrade and surgical outcomes, the long-term implications of an LN diagnosis regarding risk of developing a later breast cancer are examined. ©RSNA, 2023 Quiz questions for this article are available through the Online Learning Center.


  • Women 75 Years Old or Older: To Screen or Not to Screen?

    by Cindy S. Lee, Alana Lewin, Beatriu Reig, Laura Heacock, Yiming Gao, Samantha Heller, Linda Moy

    Breast cancer is the most common cancer in women, with the incidence rising substantially with age. Older women are a vulnerable population at increased risk of developing and dying from breast cancer. However, women aged 75 years and older were excluded from all randomized controlled screening trials, so the best available data regarding screening benefits and risks in this age group are from observational studies and modeling predictions. Benefits of screening in older women are the same as those in younger women: early detection of smaller lower-stage cancers, resulting in less invasive treatment and lower morbidity and mortality. Mammography performs significantly better in older women with higher sensitivity, specificity, cancer detection rate, and positive predictive values, accompanied by lower recall rates and false positives. The overdiagnosis rate is low, with benefits outweighing risks until age 90 years. Although there are conflicting national and international guidelines about whether to continue screening mammography in women beyond age 74 years, clinicians can use shared decision making to help women make decisions about screening and fully engage them in the screening process. For women aged 75 years and older in good health, continuing annual screening mammography will save the most lives. An informed discussion of the benefits and risks of screening mammography in older women needs to include each woman's individual values, overall health status, and comorbidities. This article will review the benefits, risks, and controversies surrounding screening mammography in women 75 years old and older and compare the current recommendations for screening this population from national and international professional organizations. ©RSNA, 2023 Quiz questions for this article are available through the Online Learning Center.


  • Breast Cancer Screening in Survivors of Childhood Cancer

    by Yiming Gao, Carmen A. Perez, Chloe Chhor, Samantha L. Heller

    Women who survived childhood cancers or cancers at a young age are at high risk for breast cancer later in life. The accentuated risk is notable among those treated at a young age with a high radiation dose but also extends to survivors treated with therapies other than or in addition to radiation therapy. The predisposing risk factors are complex. Advances in radiation therapy continue to curtail exposure, yet the risk of a second cancer has no dose threshold and a long latency period, and concurrent use of chemotherapy may have an additive effect on long-term risk of cancer. Early screening with annual mammography and MRI is recommended for chest radiation exposure of 10 Gy or greater, beginning 8 years after treatment or at age 25 years, whichever is later. However, there is a lack of recommendations for those at high risk without a history of radiation therapy. Because mortality after breast cancer among survivors is higher than in women with de novo breast cancer, and because there is a higher incidence of a second asynchronous breast cancer in survivors than that in the general population, regular screening is essential and is expected to improve mortality. However, awareness and continuity of care may be lacking in these young patients and is reflected in their poor screening attendance. The transition of care from childhood to adulthood for survivors requires age-targeted and lifelong strategies of education and risk prevention that are needed to improve long-term outcomes for these patients. © RSNA, 2023 See the invited commentary by Chikarmane in this issue. Quiz questions for this article are available through the Online Learning Center.


  • Breast Cancer Screening in Men

    by Yiming Gao, Samantha L Heller

    Breast cancer screening has been highly successful in women in reducing mortality through early detection. In comparison, clinical detection of breast cancer remains the norm in men, and delay in diagnosis is reflected by a persistent survival disparity compared to women despite advances in modern therapy. Male breast cancer presents an interesting dilemma. While mammography is highly sensitive and specific for male breast cancer, routine screening is not justified by the overall low disease incidence. Yet there has been interest in leveraging mammography in targeted screening of men with identifiable risk factors to allow early detection, and early data may support this approach. The purpose of this article is to explore the potential utility of targeted breast cancer screening in men by examining unique clinical and biologic characteristics of male breast cancers that may lend themselves to mammographic detection. We will also discuss available evidence in screening outcomes in men and summarize recent updates in risk management recommendations in Society guidelines.


  • New Horizons: Artificial Intelligence for Digital Breast Tomosynthesis

    by Julia E. Goldberg, Beatriu Reig, Alana A. Lewin, Yiming Gao, Laura Heacock, Samantha L. Heller, Linda Moy

    Artificial intelligence has significant potential to enhance the practice of digital breast tomosynthesis (DBT), the use of which may increase cancer detection rates, reduce recall rates, further r... The use of digital breast tomosynthesis (DBT) in breast cancer screening has become widely accepted, facilitating increased cancer detection and lower recall rates compared with those achieved by u...


  • Health Disparity and Breast Cancer Outcomes in Asian Women

    by Yiming Gao, Samantha L. Heller

    Health disparities in Asian women are complex and multifactorial. Screening attendance is low among Asian women, regardless of nativity or acculturation, and breast cancer detection has decreased b...